Hidden Consequences of Interim Analyses & Adaptive Trial Options

Platform trials and the future of evaluating therapeutic behavioural interventions

Adaptive design clinical trials: Methodology, challenges and prospect

European Urology Today Vol. 33 No.2 - March/May 2021 by European Association of Urology (EAU) - Issuu

Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine

Routine Functional Testing or Standard Care in High-Risk Patients after PCI

PDF) Do we need to adjust for interim analyses in a Bayesian adaptive trial design?

Hidden Consequences of Interim Analyses & Adaptive Trial Options - Quantics Biostatistics

Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus

Hidden Consequences of Interim Analyses & Adaptive Trial Options - Quantics Biostatistics

Frontiers Assessing the efficacy of immunotherapy in lung squamous carcinoma using artificial intelligence neural network